These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15297765)

  • 21. Efficacy and immunogenicity of novel erythropoietic agents and conventional rhEPO in rats with renal insufficiency.
    Tillmann HC; Kuhn B; Kränzlin B; Sadick M; Gross J; Gretz N; Pill J
    Kidney Int; 2006 Jan; 69(1):60-7. PubMed ID: 16374424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sustained efficacy of erythropoietin with a hydroxyapatite carrier administered in mice.
    Nagasaki K; Ikoma T; Katsuda S; Tonegawa T; Tanaka J; Nakamura T; Sato H; Ito S; Sasaki N; Agui T
    J Vet Med Sci; 2009 Jun; 71(6):729-36. PubMed ID: 19578280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Augmented cytoplasmic Smad4 induces acceleration of TGF-beta1 signaling in renal tubulointerstitial cells of hereditary nephrotic ICGN mice with chronic renal fibrosis; possible role for myofibroblastic differentiation.
    Goto Y; Manabe N; Uchio-Yamada K; Yamaguchi-Yamada M; Inoue N; Yamamoto Y; Ogura A; Nagano N; Miyamoto H
    Cell Tissue Res; 2004 Feb; 315(2):209-21. PubMed ID: 14615933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ratio of baseline erythropoietin (EPO) level and corrected reticulocyte count as an indicator for a favourable response to recombinant human erythropoietin (rhEPO) therapy in anaemic cancer patients.
    Charuruks N; Voravud N; Limpanasithikul W
    J Clin Lab Anal; 2001; 15(5):260-6. PubMed ID: 11574955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of recombinant human erythropoietin (SNB-5001) on renal anemic rats induced by drugs].
    Masunaga H; Takahira R; Sawai T
    Nihon Yakurigaku Zasshi; 1991 Aug; 98(2):151-60. PubMed ID: 1916543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improvement of anemia in W/WV mice by recombinant human erythropoietin (rHuEPO) mediated through EPO receptors with lowered affinity.
    Kabaya K; Akiyama H; Nishi N; Misaizu T; Okada Y; Kawagishi M; Amano K; Kusaka M; Seki M; Uzumaki H
    Life Sci; 1995; 57(11):1067-76. PubMed ID: 7658914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Erythropoietin-beta in the treatment of anemia in patients with chronic renal insufficiency].
    Dimković N
    Med Pregl; 2001; 54(5-6):235-40. PubMed ID: 11759218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Response to recombinant human erythropoietin (rHu-Epo) in a patient with chronic renal failure and myelomonocytic leukaemia.
    Salvati F; Liani M; Bonomini M
    Nephrol Dial Transplant; 2001 Jan; 16(1):191-2. PubMed ID: 11209030
    [No Abstract]   [Full Text] [Related]  

  • 29. Circulating levels of thrombopoietin and erythropoietin in hemodialysis patients.
    Otsubo Y; Nitta K; Otsubo S; Kimata N; Miwa N; Watanabe Y; Uchida K; Kawashima A; Yumura W; Akiba T; Nihei H
    Acta Haematol; 2003; 109(4):209-11. PubMed ID: 12853697
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of recombinant human erythropoietin on sodium balance in nondialysed children with chronic renal failure.
    Kavukçu S; Saatci U; Ciliv G; Söylemezoğlu O; Bakkaloğlu A; Besbas N; Ozen S
    Int Urol Nephrol; 1993; 25(6):611-5. PubMed ID: 8175282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical efficacy and safety of recombinant canine erythropoietin in dogs with anemia of chronic renal failure and dogs with recombinant human erythropoietin-induced red cell aplasia.
    Randolph JE; Scarlett J; Stokol T; MacLeod JN
    J Vet Intern Med; 2004; 18(1):81-91. PubMed ID: 14765736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of combination of bushen jianpi recipe and erythropoietin on serum tumor necrosis factor alpha in patients with anemia].
    Li QF; Ma QY; Zhu CF
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2004 Feb; 24(2):106-8. PubMed ID: 15015438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of recombinant human erythropoietin (rHu-EPO) on anemia and selected biochemical parameters in patients in the pre-dialysis period].
    Sułowicz W; Drozdz M; Hanicki Z; Kraśniak A; Kuźniewski M
    Przegl Lek; 1992; 49(1-2):50-3. PubMed ID: 1455007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erythropoiesis and erythrocyte age distribution in hemodialysis patients undergoing erythropoietin therapy.
    Hampl H; Riedel E; Scigalla P; Stabell U; Wendel G
    Blood Purif; 1990; 8(3):117-25. PubMed ID: 2244989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transforming growth factor-beta1 mediated up-regulation of lysyl oxidase in the kidneys of hereditary nephrotic mouse with chronic renal fibrosis.
    Goto Y; Uchio-Yamada K; Anan S; Yamamoto Y; Ogura A; Manabe N
    Virchows Arch; 2005 Nov; 447(5):859-68. PubMed ID: 16086153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone marrow changes following treatment of renal anemia with erythropoietin.
    Horina JH; Schmid CR; Roob JM; Winkler HM; Samitz MA; Hammer HF; Pogglitsch H; Krejs GJ
    Kidney Int; 1991 Nov; 40(5):917-22. PubMed ID: 1762296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological characterization of recombinant human erythropoietin.
    Krumwieh D; Arnold I; Seiler FR
    Behring Inst Mitt; 1988 Aug; (83):193-201. PubMed ID: 3240225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant human erythropoietin in patients with anemia due to end-stage renal disease. US multicenter trials.
    Sobota JT
    Contrib Nephrol; 1989; 76():166-78; discussion 212-8. PubMed ID: 2684519
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of recombinant human erythropoietin on hematopoietic progenitors of chronic hemodialysis patients in vitro and in vivo.
    Hino M; Miyazono K; Urabe A; Takaku F
    Int J Cell Cloning; 1989 Jul; 7(4):257-63. PubMed ID: 2768843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Excessive level of parathyroid hormone may induce the reduction of recombinant human erythropoietin effect on renal anemia.
    Fujita Y; Inoue S; Horiguchi S; Kuki A
    Miner Electrolyte Metab; 1995; 21(1-3):50-4. PubMed ID: 7565462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.